SUTACIMIG
UNII 2QP8468SQP

Substance Identification & Data

This profile provides standardized clinical and technical data for Sutacimig, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 2QP8468SQP.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2933972-64-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
2QP8468SQP
CAS Registry Number
2933972-64-4
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
SUTACIMIG
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C211722
National Cancer Institute reference terminology for clinical and research data.
INN ID
13275
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Sutacimig. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

SUTACIMIG

Common Names & Synonyms

IMMUNOGLOBULIN (H-GAMMA4_L-KAPPA)_(H-GAMMA4_L-KAPPA), ANTI-(HOMO SAPIENS F7 (COAGULATION FACTOR 7, BLOOD COAGULATION FACTOR VII, COAGULATION SERUM PROTHROMBIN CONVERSION ACCELERATOR) ACTIVATED (F7A, F7A, FVIIA, FVIIA)) AND ANTI-(HOMO SAPIENS TREML1 (TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS LIKE 1, TREM-LIKE TRANSCRIPT 1, TLT1, TLT-1)), HUMANIZED MONOCLONAL ANTIBODY, BISPECIFIC, BIVALENT
IMMUNOGLOBULIN G4 (230-PROLINE,407-LEUCINE,411-LYSINE,DE-C-TERMINAL-LYSINE), BISPECIFIC, ANTI-(HUMAN BLOOD-COAGULATION FACTOR VIIA) (HUMAN-MUS MUSCULUS MONOCLONAL 11F2 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL 11F2 .KAPPA.-CHAIN, (228->220'),(231->223')-BIS(DISULFIDE) WITH IMMUNOGLOBULIN G4 (222-PROLINE,DE-C-TERMINAL LYSINE) ANTI-(HUMAN TREM-LIKE TRANSCRIPT 1 PROTEIN) (HUMAN MONOCLONAL 0012HYB .GAMMA.4-CHAIN) DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL 0012HYB .KAPPA.-CHAIN
SUTACIMIG [INN]

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus